Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients

被引：0
|
作者：
Chunnan Liu
Zhaopei Liu
Kaifeng Jin
Han Zeng
Fei Shao
Yuan Chang
Yiwei Wang
Le Xu
Zewei Wang
Yu Zhu
Weijuan Zhang
机构：
[1] Fudan University Shanghai Cancer Center,Department of Urology
[2] Fudan University,Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences
[3] Fudan University,Department of Urology, Zhongshan Hospital
[4] Shanghai Jiao Tong University School of Medicine,Department of Oncology, Shanghai General Hospital
[5] Shanghai Jiao Tong University School of Medicine,Department of Urology, Shanghai Ninth People’s Hospital
[6] Shanghai Jiao Tong University School of Medicine,Department of Urology, Ruijin Hospital
[7] Fudan University,Department of Immunology, School of Basic Medical Sciences
来源：
British Journal of Cancer | 2022年 / 127卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1718 / 1725
页数：7
相关论文
共 50 条
  • [21] PD-L1 expression and BCG response in nonmuscle invasive bladder cancer.
    Woldu, Solomon L.
    Gerald, Thomas
    Margulis, Vitaly
    Halstuch, Daniel
    Ber, Yaara
    Lifshitz, Karin
    Margel, David
    Lotan, Yair
    Jia, Liwei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [22] Comparison of cellular composition and Expression of PD-L1/PD1 in urine and blood cells from patients with muscle-invasive bladder cancer (MIBC) with or without neoadjuvant chemotherapy
    Rodriguez Faba, Oscar
    Canto, Elisabet
    Sauch, Alba
    Zamora, Carlos
    Palou, Joan
    Maroto, Pablo
    Vidal, Silvia
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 617 - 617
  • [23] Urine PD-L1 is a tumor tissue candidate substitute and is associated with poor survival in muscle-invasive bladder cancer patients
    Ma, Jialu
    Zhou, Quan
    Xu, Wenbin
    Li, Chuangui
    Wang, Haicheng
    Zhai, Zhao
    Zhang, Yong
    Wahafu, Wasilijiang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 114
  • [24] PD-1/PD-L1 blockade in renal cell cancer
    Beckermann, Kathryn E.
    Johnson, Douglas B.
    Sosman, Jeffrey A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (01) : 77 - 84
  • [25] PD-1/PD-L1 Blockade Accelerates the Progression of Atherosclerosis in Cancer Patients
    Dong, Mei
    Yu, Ting
    Tse, Gary
    Lin, Zerun
    Lin, Chen
    Zhang, Nan
    Wang, Rujian
    Liu, Tong
    Zhong, Lin
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (03) : 1 - 20
  • [26] The prognostic significance of PD-L1 in bladder cancer
    Huang, Yide
    Zhang, Shu-Dong
    McCrudden, Cian
    Chan, Kwok-Wah
    Lin, Yao
    Kwok, Hang-Fai
    ONCOLOGY REPORTS, 2015, 33 (06) : 3075 - 3084
  • [27] Smoking status and PD-L1 mRNA-expression as a predictor of response to neoadjuvant chemotherapy in patients diagnosed with muscle invasive bladder cancer
    Reike, Moritz
    Juette, Hendrik
    Wirtz, Ralph
    Erben, Philipp
    Tully, Karl
    Eckstein, Markus
    Weyerer, Veronika
    Hartmann, Arndt
    Kriegmair, Maximilian
    Wezel, Felix
    Bolenz, Christian
    Tannapfel, Andrea
    Noldus, Joachim
    Roghmann, Florian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [28] The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
    Sui, Xinbing
    Ma, Junhong
    Han, Weidong
    Wang, Xian
    Fang, Yong
    Li, Da
    Pan, Hongming
    Zhang, Li
    ONCOTARGET, 2015, 6 (23) : 19393 - 19404
  • [29] PD-L1 as a potential biomarker in high grade non muscle invasive bladder cancer
    Gandara Cortes, M.
    Castro-Iglesias, A. M.
    Gomez de Maria, C.
    Antunez, J. R.
    Garcia-Caballero, T.
    Lopez Diez, E.
    Ortiz Rey, J. A.
    San Miguel Fraile, M. P.
    VIRCHOWS ARCHIV, 2020, 477 : S159 - S160
  • [30] Expression of PD-L1 and BCG immunotherapy in non-muscle invasive bladder cancer
    Heo, Jun Hyeok
    Jin, Hyun A.
    Kang, You Hyun
    Kim, Ki Hong
    Hong, Sung Joon
    Han, Kyung Seok
    CANCER RESEARCH, 2016, 76
12345